James Ralph Rigas MD FACP

Oncology•Hanover, NH

Hematologic Oncology, Thoracic Cancer

Professor of Medicine, Geisel School of Medicine at Dartmouth

Join to View Full Profile

3 Mulherrin Farm RdHanover, NH 03755

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1984 - 1988
MCP-Hahnemann College of MedicineClass of 1984

Certifications & Licensure

NH State Medical License 1995 - 2021
VT State Medical License 1995 - 2004

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer Start of enrollment: 1998 Nov 01
Terminated
Phase 1, Phase 2
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2005 May 01
Completed
Phase 3
A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer Start of enrollment: 2001 Aug 01
Terminated
Phase 1, Phase 2
A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer Start of enrollment: 2003 Oct 01
Completed
Phase 4
Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer Start of enrollment: 2000 Feb 01
Completed
Phase 1
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin Start of enrollment: 2011 Jan 16
Completed
Phase 3
Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer Start of enrollment: 2010 Jul 01
Completed
Join now to see all

Publications & Presentations

PubMed

2 citations
Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark.
Elizabeth Hedgeman, Mette Nørgaard, Tapashi Dalvi, Lars Pedersen, Hanh Hansen
Cancer Epidemiology. 2021-07-01
1 citations
A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer.
Matthew B. Schabath, Tapashi Dalvi, Hongyue A Dai, Alan Crim, Anita Midha
Cancer Management and Research. 2019-11-07
44 citations
ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer.
Filippo de Marinis, Yi-Long Wu, Gilberto de Castro, Gee-Chen Chang, Yuh Min Chen
Future Oncology. 2019-07-24

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
International Association for the Study of Lung Cancer
Member